Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Amicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date February 11, 2018 New Jersey Startup Launches With Clinical Assets From Big Name Biotechs August 21, 2017 Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017
Amicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date February 11, 2018
Tauriga Secures Investment Of $80,000 USD Through A 5% Promissory Note With Fixed Conversion Price Of $0.00125 Per Share June 29, 2017
